Management of Recurrent Streptococcal Pharyngitis

Diagnosis and Initial Assessment

• Confirm streptococcal infection with a rapid antigen detection test or throat culture before prescribing antibiotics, because clinical features alone cannot reliably differentiate bacterial from viral pharyngitis. 1
• For a patient who has recently completed therapy for strep throat and now presents with a new episode, the same first‑line antibiotic (penicillin V or amoxicillin for 10 days) should be prescribed unless there is documented treatment failure or evidence of chronic carriage. 1

First‑Line Therapy for Non‑Allergic Patients

• Penicillin V – 250 mg orally twice daily for 10 days in children or 500 mg twice daily for 10 days in adults; chosen because there is zero documented resistance worldwide, a narrow spectrum, proven efficacy in preventing acute rheumatic fever, and low cost. 1
• Amoxicillin – 50 mg/kg once daily (max 1000 mg) or 25 mg/kg twice daily (max 500 mg per dose) for 10 days; equally effective and preferred in children for better palatability. 1
• A full 10‑day course is mandatory to achieve maximal pharyngeal eradication and to prevent acute rheumatic fever; shortening the course by even a few days markedly increases treatment‑failure rates. 1
• Intramuscular benzathine penicillin G (600,000 U for <27 kg; 1.2 million U for ≥27 kg) should be considered when adherence to oral therapy is doubtful, as it guarantees complete treatment. 1

Alternatives for Penicillin‑Allergic Patients

Non‑Immediate (Delayed) Penicillin Allergy

• First‑generation cephalosporins (e.g., cephalexin 500 mg twice daily or cefadroxil 1 g once daily in adults; cephalexin 20 mg/kg twice daily, max 500 mg per dose, in children) are the preferred alternatives, supported by strong, high‑quality evidence. 1
• The risk of cross‑reactivity in patients with delayed, mild penicillin reactions is only ~0.1%. 1

Immediate/Anaphylactic Penicillin Allergy

• Clindamycin (300 mg orally three times daily for 10 days in adults; 7 mg/kg three times daily, max 300 mg per dose, in children) is the preferred choice, backed by strong, moderate‑quality evidence. 1
• Clindamycin resistance among U.S. Group A Streptococcus isolates is approximately 1%, and the drug shows superior eradication even in chronic carriers. 1
• All β‑lactams must be avoided in immediate hypersensitivity because cross‑reactivity with cephalosporins can reach 10%. 1

Macrolide Options (Less Preferred)

• Azithromycin 500 mg once daily for 5 days in adults or 12 mg/kg once daily (max 500 mg) for 5 days in children is acceptable when clindamycin cannot be used; macrolide resistance in the United States ranges from 5–8%. 1
• Clarithromycin 250 mg twice daily for 10 days in adults or 7.5 mg/kg twice daily (max 250 mg per dose) in children carries similar resistance concerns. 1
• Azithromycin is the only agent that can be given for a shortened 5‑day course because of its prolonged tissue half‑life; all other agents require the full 10‑day regimen. 1

Management of Documented Treatment Failure or Chronic Carriage

• If compliance is confirmed, GAS infection is verified, and symptoms persist after a 10‑day course of penicillin or amoxicillin, switch to one of the following regimens, which are substantially more effective at eliminating chronic carriage:
  
  • Clindamycin 20–30 mg/kg/day divided into three doses for 10 days.
  • Amoxicillin‑clavulanate 40 mg amoxicillin/kg/day divided into three doses for 10 days.
  • Penicillin V + rifampin – Penicillin V 50 mg/kg/day in four doses (max 2000 mg/day) for 10 days plus rifampin 20 mg/kg/day in a single dose for the final 4 days (max 600 mg/day).
  • Benzathine penicillin G + rifampin – Single dose of benzathine penicillin G (600,000 U <27 kg; 1.2 million U ≥27 kg) plus rifampin 20 mg/kg/day in two doses for 4 days (max 600 mg/day).
• These alternative regimens are recommended based on evidence that they achieve higher eradication rates in chronic carriers. 1

Distinguishing Chronic Carriage from True Recurrent Infection

• Most patients with frequent, discrete episodes are chronic streptococcal carriers experiencing intercurrent viral infections rather than true recurrent GAS pharyngitis. 1
• Clues suggesting chronic carriage include school‑age or adolescent status, seasonal patterns, local epidemiology, and the specific nature of signs and symptoms. 1
• Chronic carriers generally do not require antimicrobial therapy unless special circumstances exist (e.g., community outbreak of rheumatic fever, family history of rheumatic fever, significant family anxiety, or tonsillectomy being considered solely to eliminate carriage). 1
• Routine post‑treatment throat cultures are not indicated for asymptomatic patients who have completed therapy; they should be reserved for special situations such as a prior history of rheumatic fever. 1

Common Pitfalls to Avoid

• Do not shorten the antibiotic course below 10 days (except the azithromycin 5‑day regimen), as this dramatically raises the risk of treatment failure and rheumatic fever. 1
• Do not use cephalosporins in patients with immediate or anaphylactic penicillin reactions because of a 10% cross‑reactivity risk. 1
• Do not prescribe trimethoprim‑sulfamethoxazole for strep throat; it fails to eradicate GAS in 20–25% of cases. 1
• Do not assume every recurrent episode represents a new infection; many are chronic carriers with concurrent viral illnesses. 1

Treatment of Streptococcal Pharyngitis

First-Line Treatment for Non-Allergic Patients

• The American Academy of Pediatrics and the Infectious Diseases Society of America recommend penicillin V or amoxicillin for 10 days to achieve maximal pharyngeal eradication of Group A Streptococcus and prevent acute rheumatic fever 2, 3
• Penicillin V 250 mg orally twice daily for 10 days is the standard regimen for children, while adults typically receive 500 mg twice daily 2
• The Infectious Diseases Society of America suggests that intramuscular benzathine penicillin G should be used when compliance with oral therapy is questionable, particularly in populations where rheumatic fever remains prevalent 2, 4

Treatment for Penicillin-Allergic Patients

• The American Academy of Pediatrics recommends first-generation cephalosporins, such as cephalexin 500 mg twice daily or cefadroxil 1 gram once daily for 10 days, as the preferred first-line alternatives for patients without immediate hypersensitivity reactions 2, 3
• The Infectious Diseases Society of America notes that cross-reactivity risk with first-generation cephalosporins is only 0.1% in patients with non-immediate penicillin reactions 3
• For patients with immediate hypersensitivity reactions, the American Academy of Pediatrics recommends clindamycin as the preferred choice, with a regimen of 300 mg orally three times daily for 10 days for adults and 7 mg/kg per dose three times daily for children 2, 3, 5

Critical Treatment Duration Requirements

• The Infectious Diseases Society of America emphasizes that a full 10-day course is essential for all antibiotics except azithromycin to achieve maximal pharyngeal eradication and prevent acute rheumatic fever 2, 3, 4
• The American Academy of Pediatrics notes that azithromycin requires only 5 days due to its prolonged tissue half-life 2, 3
• Shortening the course by even a few days results in appreciable increases in treatment failure rates, according to the Infectious Diseases Society of America 3

Supportive Care and Adjunctive Therapy

• The American Academy of Pediatrics recommends acetaminophen or NSAIDs, such as ibuprofen, as adjunctive therapy for moderate to severe symptoms or high fever 2, 5
• The Infectious Diseases Society of America advises that aspirin must be avoided in children due to Reye syndrome risk 2, 5
• The American Academy of Pediatrics states that corticosteroids are not recommended 2, 5

Clinical Response Timeline

• Patients typically experience noticeable clinical improvement within 24-48 hours of starting antibiotics, according to the Infectious Diseases Society of America 4
• The American Academy of Pediatrics notes that patients are no longer contagious after 24 hours of appropriate antibiotic therapy 4
• Symptoms typically resolve within less than 1 week even without antibiotics, but antibiotics shorten duration by approximately 1-2 days, according to the Infectious Diseases Society of America 4

Common Pitfalls to Avoid

• The Infectious Diseases Society of America warns that cephalosporins should not be used in patients with immediate/anaphylactic penicillin reactions due to 10% cross-reactivity risk 3, 5
• The American Academy of Pediatrics advises that azithromycin should not be prescribed as first-line therapy, but only used when penicillin and preferred alternatives cannot be used 3
• The Infectious Diseases Society of America emphasizes that local macrolide resistance patterns should not be ignored, as resistance varies geographically and can lead to treatment failure 3, 5

Special Considerations

• The American Academy of Pediatrics recommends that testing should only be considered in special circumstances, such as patients with a history of rheumatic fever 4
• The Infectious Diseases Society of America notes that chronic carriers generally do not require treatment, as they are unlikely to spread infection or develop complications 2, 3